Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques

References

• Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet. 2020;395(10225):689–697.
   PubMed Web of Science ®Google Scholar
• WHO. COVID-19 vaccine tracker and landscape. 2022: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
   Google Scholar
• Plummer MM, Pavia CS. COVID-19 vaccines for HIV-infected patients. Viruses. 2021 Sep 22;13(10):1890.
   PubMed Web of Science ®Google Scholar
• Frater J, Ewer KJ, Ogbe A, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet HIV. 2021 Aug;8(8):e474–e485.
   PubMed Web of Science ®Google Scholar
• Woldemeskel BA, Karaba AH, Garliss CC, et al. The BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2022 Apr 9;74(7):1268–1270.
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhang Y, He Z, et al. Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study. EClin Med. 2022 Jan;43:101226.
   PubMedGoogle Scholar
• WHO. HIV/AIDS. 2022: https://www.who.int/news-room/fact-sheets/detail/hiv-aids.
   Google Scholar
• Morou A, Palmer BE, Kaufmann DE. Distinctive features of CD4+ T cell dysfunction in chronic viral infections. Curr Opin HIV AIDS. 2014;9(5):446–451.
   PubMed Web of Science ®Google Scholar
• Maponga TG, Jeffries M, Tegally H, et al. Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection SSRN. 2022;4014499.
   Google Scholar
• Cele S, Karim F, Lustig G, et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe. 2022;30(2):154–162.e5. e5.
   PubMed Web of Science ®Google Scholar
• Corey L, Beyrer C, Cohen MS, et al. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385(6):562–566.
   PubMed Web of Science ®Google Scholar
• Scialo F, Daniele A, Amato F, et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung. 2020;198(6):867–877.
   PubMed Web of Science ®Google Scholar
• Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 2021;27(7):1205–1211.
   PubMed Web of Science ®Google Scholar
• Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011;29:621–663.
   PubMed Web of Science ®Google Scholar
• Aid M, Dupuy FP, Moysi E, et al. Follicular CD4 T helper cells as a major HIV reservoir compartment: a molecular perspective. Front Immunol. 2018;9:895.
   PubMed Web of Science ®Google Scholar
• Pallikkuth S, Sharkey M, Babic DZ, et al. Peripheral T follicular helper cells are the major HIV reservoir within central memory CD4 T cells in peripheral blood from chronically HIV-infected individuals on combination antiretroviral therapy. J Virol 2015 Dec 16;90(6):2718–2728.
   PubMed Web of Science ®Google Scholar
• Chakhtoura M, Fang M, Cubas R, et al. Virulence and community dynamics of fungal species with vertical and horizontal transmission on a plant with multiple infections. PLoS Pathog 2021;17(7):e1009769.
   PubMed Web of Science ®Google Scholar
• Boppana S, Qin K, Files JK, et al. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence. PLoS Pathog 2021;17(7):e1009761.
   PubMed Web of Science ®Google Scholar
• Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol. 2012;12(2):136–148.
   PubMed Web of Science ®Google Scholar
• Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398(10317):2126–2128.
   PubMed Web of Science ®Google Scholar
• Feng L, Wang Q, Shan C, et al. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Nat Commun. 2020;11(1):4207.
   PubMed Web of Science ®Google Scholar
• Nie J, Li Q, Wu J, et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020;15(11):3699–3715.
   PubMed Web of Science ®Google Scholar
• Sun C, Chen Z, Tang X, et al. Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys. J Virol 2013;87(10):5755–5777.
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang L, Niu X, et al. Phenotypic characterization of Chinese rhesus macaque plasmablasts for cloning antigen-specific monoclonal antibodies. Front Immunol. 2019;10:2426.
   PubMed Web of Science ®Google Scholar
• Wu T, Ma F, Ma X, et al. Regulating innate and adaptive immunity for controlling SIV infection by 25-hydroxycholesterol. Front Immunol. 2018;9:2686.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhang Y, Feng L, et al. Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, Southern China. Vaccine. 2011;29(22):3837–3841.
   PubMed Web of Science ®Google Scholar
• Phillips AN, Staszewski S, Weber R, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. Jama. 2001;286(20):2560–2567.
   PubMed Web of Science ®Google Scholar
• Korobchuk A, Davtyan H, Denisiuk O, et al. People with high HIV viral load within risk networks: who are these people and who refers them best? J Infect Dev Ctries. 2019 Jul;13(7 Suppl):103S–110S.
   PubMed Web of Science ®Google Scholar
• Roltgen K, Boyd SD. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021;29(7):1063–1075.
   PubMed Web of Science ®Google Scholar
• Breton G, Mendoza P, Hagglof T, et al. Persistent cellular immunity to SARS-CoV-2 infection. J Exp Med 2021 Apr 5;218(4).
   PubMed Web of Science ®Google Scholar
• Sun C, Feng L, Zhang Y, et al. Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques. J Virol 2012;86(20):11031–11042.
   PubMed Web of Science ®Google Scholar
• Ruddy JA, Boyarsky BJ, Werbel WA, et al. Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV. Aids. 2021;35(11):1872–1874.
   PubMed Web of Science ®Google Scholar
• Geretti AM, Doyle T. Immunization for HIV-positive individuals. Curr Opin Infect Dis 2010;23(1):32–38.
   PubMed Web of Science ®Google Scholar
• Matthew Gagne JIM, Foulds KE, Andrew SF, et al. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron. medRxiv. 2022.
   Google Scholar
• Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9(4):235–245.
   PubMed Web of Science ®Google Scholar
• Nicholas KJ, Flaherty DK, Smith RM, et al. Chronic HIV-1 infection impairs superantigen-induced activation of peripheral CD4+CXCR5+PD-1+ cells, with relative preservation of recall antigen–specific responses. JAIDS J Acquir Immune Defic Syndr. 2017;74(1):72–80.
   PubMed Web of Science ®Google Scholar
• D'Orsogna LJ, Krueger RG, McKinnon EJ, et al. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy. Aids. 2007;21(13):1747–1752.
   PubMed Web of Science ®Google Scholar
• Pusnik J, Richter E, Schulte B, et al. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help. Cell Rep. 2021;35(13):109320.
   PubMed Web of Science ®Google Scholar
• Winklmeier S, Eisenhut K, Taskin D, et al. Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG. iScience. 2022;25(1):103659.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shi J, Yan J, et al. Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells. Nat Immunol 2017;18(8):921–930.
   PubMed Web of Science ®Google Scholar
• Mizuma H, Litwin S, Zolla-Pazner S. B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters. Clin Exp Immunol 1988 Mar;71(3):410–416.
   PubMed Web of Science ®Google Scholar
• Callaway E. Omicron likely to weaken COVID vaccine protection. Nature. 2021;600(7889):367–368.
   PubMed Web of Science ®Google Scholar
• Fuster F, Vargas JI, Jensen D, et al. CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: a prospective cohort study. Vaccine. 2016;34(16):1889–1895.
   PubMed Web of Science ®Google Scholar
• Avelino-Silva VI, Miyaji KT, Hunt PW, et al. CD4/CD8 ratio and KT ratio predict yellow fever vaccine immunogenicity in HIV-infected patients. PLoS Negl Trop Dis. 2016 Dec;10(12):e0005219.
   PubMed Web of Science ®Google Scholar
• Sato H, Adachi E, Lim LA, et al. CD4/CD8 ratio predicts the cellular immune response to acute hepatitis C in HIV-coinfected adults. J Infect Chemother. 2019;25(8):646–648.
   PubMed Web of Science ®Google Scholar
• Loffredo JT, Bean AT, Beal DR, et al. Patterns of CD8 + immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J Virol 2008;82(4):1723–1738.
   PubMed Web of Science ®Google Scholar
• Karlsson AC, Martin JN, Younger SR, et al. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods. 2003;283(1-2):141–153.
   PubMed Web of Science ®Google Scholar
• Crotty S, Aubert RD, Glidewell J, et al. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods. 2004;286(1-2):111–122.
   PubMed Web of Science ®Google Scholar
• Gilbert PB, Montefiori DC, McDermott AB, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 2022;375(6576):43–50.
   PubMed Web of Science ®Google Scholar
• Corbett KS, Gagne M, Wagner DA, et al. Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates. Science. 2021;374(6573):1343–1353.
   PubMed Web of Science ®Google Scholar
• McMahan K, Yu J, Mercado NB, et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021;590(7847):630–634.
   PubMed Web of Science ®Google Scholar
• Cheeseman SH, Davaro RE, Ellison RT. 3rd. Hepatitis B vaccination and plasma HIV-1 RNA. N Engl J Med 1996 May 9;334(19):1272.
   PubMed Web of Science ®Google Scholar